Clinical Trials Browser

Pituitary Neoplasms × Temozolomide × Endocrine × Clear all

Pituitary Neoplasms

NCT00601289 2020-07-31

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Pituitary Neoplasms, Prolactinoma, Central Nervous System Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

NCT04244708 2020-01-28

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Phase 2/3 Unknown

150 enrolled

Endocrine

Pituitary Neoplasms

Clinical Trials

TMZ-Cap

Temozolomide in Treating Patients With Invasive Pituitary Tumors

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas